Antiphospholipid antibodies in primary Sjögren's syndrome: Prevalence and clinical significance in a series of 74 patients

Lupus

Volumn 13, Issue 4, 2004, Pages 245-248

  Fauchais, Anne Laure ^a   Lambert, M ^a   Launay, D ^a   Michon Pasturel, U ^a   Queyrel, V ^a   Nguyen, N ^a   Hebbar, M ^a   Hachulla, E ^a   Devulder, B ^a   Hatron, P Y ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antiphospholipid antibodies; Hypergammaglobulinemia; Sj gren's syndrome

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; FEMALE; FETUS WASTAGE; HUMAN; HYPERGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; THYROIDITIS; VEIN THROMBOSIS;

EID: 2442607522     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1006oa     Document Type: Article

References (28)

1. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 1965; 44: 187-231.
2. Kater L, De Wilde P. New developments in Sjögren's syndrome. Curr Opin Rheumatol 1992; 4: 657-65.
3. Asherson RA, Baguley E, Pal C, Hughes GR. Antiphospholipid syndrome: five year follow up. Ann Rheum Dis 1991; 50: 805-10.
4. Ames PR, Khamashta MA, Hughes GR. Clinical and therapeutic aspects of the antiphospholipid syndrome. Lupus 1995; 4 (Suppl 1): S23-S25.
5. Asherson RA, Cervera R. 'Primary', 'secondary' and other variants of the antiphospholipid syndrome. Lupus 1994; 3: 293-98.
6. Asherson RA, Fei HM, Staub HL, Khamashta MA, Hughes GR, Fox RI. Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. Ann Rheum Dis 1992; 51: 495-98.
7. Cervera R, Garcia-Carrasco M, Font J et al. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 1997; 15: 361-65.
8. Jedryka-Goral A, Jagiello P, D'Cruz DP, et al. Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis 1992; 51: 889-991.
9. Pennec YL, Magadur G, Jouquan J, Youinou P. Serial measurements of anticardiolipin antibodies in primary Sjögren's syndrome. Clin Exp Rheumatol 1991; 9: 165-70.
10. McCarty-Farid GA. Antiphospholipid antibodies in systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 1993; 5: 596-603.
11. Vitali C, Bombardieri S, Moutsopoulos HM et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996; 55: 116-21.
12. Chisholm D, Masson D. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968; 2: 656-60.
13. Harris E. The second internationnal anticardiolipin standardization workshop/The Kingstone Antiphospholipid Antibody Study Group. Am J Clin Pathol 1990; 94: 474-84.
14. Brandt J, Triplett D, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-90.
15. Yamoaka K, Miyasaka N, Sato K, Okuda M, Nishioka K. B cell hyperresponsiveness in Sjögren's syndrome. Autoimmunity 1989; 3: 261-69.
16. Manoussakis MN, Gharavi AE, Drosos AA, Kitridou RC, Moutsopoulos HM. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 1987; 44: 297-307.
17. Davidson BK, Kelly CA, Griffiths ID. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology (Oxford) 1999; 38: 245-53.
18. Ingram S, Goodnight S, Bennett R. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of 2 cases. Arthritis Rheum 1987; 30: 1167-72.
19. Buchanan RR, Wardlaw JR, Riglar AG, Littlejohn GO, Miller MH. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease. J Rheumatol 1989; 16: 757-61.
20. Biyajima S, Osada T, Daidoji H et al. Pulmonary hypertension and antiphospholipid antibody in a patient with Sjögren's syndrome. Intern Med 1994; 33: 768-72.
21. Julkunen H, Kaaja R, Kurki P, Palosuo T, Friman C. Fetal outcome in women with primary Sjögren's syndrome. A retrospective case-control study. Clin Exp Rheumatol 1995; 13: 65-71.
22. Coates T, Slavotinek JP, Rischmueller M et al. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. J Rheumatol 1999; 26: 1301-305.
23. Hughes T, Jones P, Rozenberg M. Hypergammaglobulinemia and the anticardiolipin antibody test. Arthritis Rheum 1989; 32: 813.
24. Staub H, Chahade W, Khamashta M, Szajubok J, Hughes G. False-positive IgM anticardiolipin antibody in the presence of rheumatoid factor. Arthritis Rheum 1989; 32(Suppl): B 135.
25. Vitali C, Sciuto M, Neri R et al. Anti-hepatitis C virus antibodies in primary Sjogren's syndrome: false positive results are related to hypergammaglobulinemia. Clin Exp Rheumatol 1992; 10: 103-104.
26. Wen CL, Wang CR, Chuang CY, Chen CY. Increased production of interleukin-6 and autoantibodies in patients with Sjogren's syndrome. Chung Hua Min Kuo Wei Sheng Wu Chi Mien I Hsueh Tsa Chih 1992; 25: 1189-95.
27. Halse ATP, Wahren-Herlenius M, Haga H, Jonsson R. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome. Scand J Immunol 1999; 49: 533-38.
28. Lambert M, Launay D, Fauchais AL et al. Anticardiolipin antibodies IgG associated to an hypergammaglobulinemia are not thrombotic markers: about 294 patients. J Autoimmun 2000; 15: A55.